VERDOT®

VERDOT®, established in 1950 and headquartered in Riom, France, stands at the forefront of downstream bioprocessing technology. VERDOT focuses on innovative purification solutions for the biopharmaceutical industry, including chromatography columns and custom and standardized chromatography and tangential flow filtration (TFF) systems. VERDOT® systems and columns are employed in the purification, separation and concentration of biomolecules such as monoclonal antibodies, vaccines, viral vectors (e.g., AAV and lentivirus), and mRNA-based therapeutics. VERDOT® serves a diverse customer base, including research and development, early-stage biotech, biopharma, and CDMOs in all stages of the drug development workflow from exploration through to manufacturing of commercially available biologics. VERDOT's tailored, high-quality purification technologies empower their customers to accelerate time-to-market of groundbreaking and cost-effective therapies.